A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2011
12/14/2011	CN102008681B 一种治疗胸痛的中药组合物及其制备方法 A treatment for chest pain medicine composition and its preparation method
12/14/2011	CN102008518B Seabuckthorn seed oil liposome preparation process
12/14/2011	CN101953991B Medicine used for curing chronic cardiac insufficiency and preparation method thereof
12/14/2011	CN101926859B 一种治疗痔疮的中药组合物 A treatment for hemorrhoids herbal composition
12/14/2011	CN101912529B 一种超声提取多穗金粟兰总黄酮的方法 An ultrasonic extraction method multiple ear Chloranthus total flavonoids
12/14/2011	CN101912493B 治疗心脑血管类疾病穴位贴膏 Treatment of cardiovascular diseases Plaster points
12/14/2011	CN101897676B 一种替米沙坦片剂组合物 One kind of telmisartan tablet composition
12/14/2011	CN101874891B 一种治疗心悸的中药组合物及其制备方法 An palpitations Chinese medicine composition and preparation method of treatment
12/14/2011	CN101874887B 一种治疗心绞痛的中药组合物及其制备方法 A treatment for angina medicine composition and its preparation method
12/14/2011	CN101874784B 析出结晶药物缓控释微球粒及其制备方法 Precipitation of crystalline drug controlled release microsphere and its preparation method
12/14/2011	CN101869689B 治疗心绞痛型冠心病的外用中药组合物 Chinese medicine composition for topical treatment of angina, coronary artery disease
12/14/2011	CN101836981B 复方缬沙坦苯磺酸氨氯地平药物组合物及其制备方法 Compound Valsartan Amlodipine pharmaceutical compositions and methods for preparing
12/14/2011	CN101810843B 一种治疗脑梗塞后遗症和急性脊髓炎的药物 A treatment for sequelae of cerebral infarction and acute myelitis drugs
12/14/2011	CN101732514B 治疗风湿、类风湿和颈腰椎病的药 Rheumatism, rheumatoid and cervical lumbar medicine
12/14/2011	CN101643466B 一种高纯度的表没食子儿茶素没食子酸酯及其制备方法 A high-purity Epigallocatechin gallate and its preparation method
12/14/2011	CN101642568B 一种红景天组合物 Rhodiola one kind of composition
12/14/2011	CN101569680B 一种治疗痔疮的内服中药及其制备方法 An internal medicine and its preparation method for the treatment of hemorrhoids
12/14/2011	CN101544677B 一种植物甾醇脂肪酸酯及其制备方法 One phytosterol fatty acid ester and preparation method
12/14/2011	CN101524387B 苦碟子注射液制备工艺及在制备治疗心脑血管疾病药物中的应用 Preparation KDZ and in the preparation of the treatment of cardiovascular and cerebrovascular diseases medicine
12/14/2011	CN101485697B 银杏酮酯分散片及其制备方法 Ginkgo Biloba tablet and its preparation method
12/14/2011	CN101472905B 作为酰基辅酶甘油二酯酰基转移酶的抑制剂的取代的5-苯基氨基-1,3,4-噁二唑-2-基羰基氨基-4-苯氧基-环己烷甲酸 Examples of the acyl coenzyme diacylglycerol acyltransferase inhibitors of 5-phenyl-substituted amino-1,3,4-oxadiazol-2-yl-carbonyl-amino-4-phenoxy-- cyclohexanecarboxylic acid
12/14/2011	CN101455696B 一种富含呋甾皂苷的蒺藜全草提取物及其制备方法 A rich source of saponins from Tribulus furostanol whole plant extract and its preparation method
12/14/2011	CN101332263B 降低冠心病血小板聚集率的中药及其制备方法 Chinese medicine and its preparation method reduces platelet aggregation rate of coronary heart disease
12/14/2011	CN101301425B 治疗糖尿病的药物组合物 A pharmaceutical composition for treating diabetes
12/14/2011	CN101143190B 用于痔毒疮的中药制剂 Canker of Chinese medicine for hemorrhoids
12/13/2011	US8076502 2-amino-bicyclo(3.1.0) hexane-2,6-dicarboxylic ester derivative
12/13/2011	US8076368 Percutaneous absorption type cerebral protective agent
12/13/2011	US8076339 Pyridazinyl amine derivatives, the use thereof in the preparation of picorna virus inhibitors
12/13/2011	US8076336 Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments
12/13/2011	US8076324 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
12/13/2011	US8076283 Methods for treating congestive heart failure
12/13/2011	US8076098 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
12/13/2011	US8075914 Controlled release melatonin
12/13/2011	CA2539070C Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
12/13/2011	CA2530938C Compounds, formulations, and methods for treating or preventing rosacea
12/13/2011	CA2494628C Acylated arylcycloalkylamines and their use as pharmaceuticals
12/13/2011	CA2475821C Group b streptococcus antigens
12/13/2011	CA2425316C A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade
12/13/2011	CA2386954C Methods of treating vascular diseases characterized by nitric oxide insufficiency
12/13/2011	CA2358520C Soluble receptor br43x2 and methods of using
12/08/2011	WO2011153226A2 Cellular constituents from bacteroides, compositions thereof, and therapeutic methods employing bacteroides or cellular constituents thereof
12/08/2011	WO2011153192A2 Cytochrome p450 inhibitors and uses thereof
12/08/2011	WO2011152662A2 Ptd-uqcrb fusion polypeptide, and pharmaceutical composition for preventing and treating ischemic diseases, containing same
12/08/2011	WO2011152524A1 Cell growth-promoting peptide and use thereof
12/08/2011	WO2011152508A1 Optically active dibenzylamine derivative, and manufacturing method for same
12/08/2011	WO2011152411A1 Crystal of thienopyrimidine derivative
12/08/2011	WO2011152330A1 Soybean protein hydrolysate-containing antioxidant and use thereof
12/08/2011	WO2011151251A1 New ccr2 antagonists
12/08/2011	WO2011102695A9 Composition for preventing or treating diseases caused by over-expression of lxrα, containing liquiritigenin or isoliquiritigenin as active ingredient
12/08/2011	WO2011100453A3 Compositions and methods for the treatment of cardiac and vascular disease
12/08/2011	WO2011072275A3 Agents and methods for treating ischemic and other diseases
12/08/2011	WO2010128401A9 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
12/08/2011	US20110301568 Systems and Methods to Treat Cardiac Pacing Conditions
12/08/2011	US20110301248 Compositions and methods of delivery of pharmacological agents
12/08/2011	US20110301245 (r)-2-(3,4-dimethoxyphenol)-2-isopropyl-6-azaheptanitril formulaitons, andthe use of such formulations in the treatment of conditions mediated by the serotonin transporter
12/08/2011	US20110301239 Use of novel lipid mediators to inhibit angiogenesis
12/08/2011	US20110301235 Organoselenium compounds and uses thereof
12/08/2011	US20110301225 Compounds and Methods for Reducing the Recruitment and/or Migration of Polymorphonuclear Cells
12/08/2011	US20110301217 Selective Glycosidase Inhibitors and Uses Thereof
12/08/2011	US20110301215 Inhibitors of plasma kallikrein
12/08/2011	US20110301211 Antagonists of lysophosphatidic acid receptors
12/08/2011	US20110301193 Methods and compositions of targeted drug development
12/08/2011	US20110301191 Methods of treatment using selective 5-ht2a inverse agonists
12/08/2011	US20110301186 Use of haptoglobin genotyping in diagnosis and treatment of cardiovascular disease
12/08/2011	US20110301180 Reducing Platelet Activation, Aggregation and Platelet-Stimulated Thrombosis or Blood Coagulation by Reducing Mitochondrial Respiration
12/08/2011	US20110301175 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
12/08/2011	US20110301168 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
12/08/2011	US20110301161 Benzimidazole inhibitors of leukotriene production
12/08/2011	US20110301160 Inhibitors of P38 and Methods of Using the Same
12/08/2011	US20110301158 Aryl carbonyl derivatives as therapeutic agents
12/08/2011	US20110301157 Bicyclic amides as kinase inhibitors
12/08/2011	US20110301156 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof to Treat Pain and Other Conditions
12/08/2011	US20110301149 Compositions and methods for treating alcohol use disorders, pain and other diseases
12/08/2011	US20110301148 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
12/08/2011	US20110301136 Nitrate Esters Of Corticoid Compounds Useful As Diuretics
12/08/2011	US20110301134 Alkyne antagonists of lysophosphatidic acid receptors
12/08/2011	US20110301133 Compositions of protein receptor tyrosine kinase inhibitors
12/08/2011	US20110301128 Pyrrole Derivatives As Pharmaceutical Agents
12/08/2011	US20110301122 Heteroaromatic compounds for use as hif inhibitors
12/08/2011	US20110301112 Fused ring thrombin receptor antagonists
12/08/2011	US20110301109 Phenylpyrimidone Compounds, the Pharmaceutical Compositions, Preparation Methods and Uses Thereof
12/08/2011	US20110301100 Pharmaceutical Compositions Comprising Polyethylene Glycol Having a Molecular Weight of Less Than 600 Daltons
12/08/2011	US20110301098 Treatment for intimal hyperplasia and related conditions
12/08/2011	US20110301096 Prodrug of an ice inhibitor
12/08/2011	US20110301089 Adiponectin receptor fragments and methods of use
12/08/2011	US20110301080 Pharmaceutical compositions
12/08/2011	US20110301079 Neuromedin u receptor agonists and uses thereof
12/08/2011	US20110300237 Protective solutions for organs
12/08/2011	US20110300221 Therapeutic Inhibitor of Vascular Smooth Muscle Cells
12/08/2011	US20110300218 Novel solid state forms of ranolazine salts
12/08/2011	US20110300214 Pharmaceutical compositions comprising 5-chloro-n-(-methyl)-2-thiophencarboxamid
12/08/2011	US20110300213 Oral formulations of bipolar trans carotenoids
12/08/2011	US20110300209 Modified release solid pharmaceutical compositions of trimetazidine and process thereof
12/08/2011	US20110300199 Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions
12/08/2011	US20110300172 Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis
12/08/2011	US20110300160 Sulfation of wnt pathway proteins
12/08/2011	US20110300157 Metalloproteinase 9 and metalloproteinase 2 binding proteins
12/08/2011	US20110300155 Modulating xrn2
12/08/2011	US20110300149 Ljungan virus
12/08/2011	US20110300142 Use of zeburaline for the treatment of autoimmune diseases or immune rejection of transplants

1 ... 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 ... 1595